Other compound targeting SOCE is the biomolecule Ohmline, a Edelfosine mimetic, that inhibits breast and colon cancer cells migration through the TRPC1/ORAI1/SK3 complex dissociation (Guéguinou et al., 2016). This evidence concerns the gene TRPC1 and colonic neoplasm.